ArcBest: Goldman Sachs maintains neutral rating and raised the target to $100 from $90.
Ares Management: UBS raised the target to $82 from $68. Maintains buy rating.
Axonics: Piper Sandler adjusts price target to $82 from $77. Reiterates overweight rating.
Burlington Stores: Goldman Sac…
© MarketScreener.com 2022
previous post